Multidrug-resistant TB gets backing from drug giant

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.416, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluoroquinolones, surgery in multidrug-resistant TB

Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Multidrug-resistant TB `a curable disease'

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Strategies to fight multidrug resistant TB

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Analysis of Drug Transport Kinetics in Multidrug-resistant Cells: Implications for Drug Action

Current Medicinal Chemistry, Vol. 8, Iss. 1, 2001-01 ,pp. : 51-64

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid A Biosynthesis of Multidrug-Resistant Pathogens - A Novel Drug Target

Current Pharmaceutical Design, Vol. 19, Iss. 36, 2013-11 ,pp. : 6534-6550

Bentham Science Publishers

Access to resources Recommend Favorite